202 related articles for article (PubMed ID: 25986910)
1. Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization : Fifty Years of Revascularization: Where Are We and Where Are We Heading?
Costa F; Ariotti S; Valgimigli M; Kolh P; Windecker S;
J Cardiovasc Transl Res; 2015 Jun; 8(4):211-20. PubMed ID: 25986910
[TBL] [Abstract][Full Text] [Related]
2. Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.
Yates MT; Soppa GK; Valencia O; Jones S; Firoozi S; Jahangiri M
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):606-10. PubMed ID: 23402690
[TBL] [Abstract][Full Text] [Related]
3. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
Byrne RA; Fremes S; Capodanno D; Czerny M; Doenst T; Emberson JR; Falk V; Gaudino M; McMurray JJV; Mehran R; Milojevic M; Uva MS
Eur J Cardiothorac Surg; 2023 Aug; 64(2):. PubMed ID: 37632766
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Coronary Artery Disease: Randomized Trials on Myocardial Revascularization and Complete Arterial Bypass Grafting.
Rastan AJ
Thorac Cardiovasc Surg; 2017 Apr; 65(S 03):S167-S173. PubMed ID: 28388767
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials.
Nerlekar N; Ha FJ; Verma KP; Bennett MR; Cameron JD; Meredith IT; Brown AJ
Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27899408
[TBL] [Abstract][Full Text] [Related]
6. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
[TBL] [Abstract][Full Text] [Related]
7. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
[TBL] [Abstract][Full Text] [Related]
8. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
Byrne RA; Fremes S; Capodanno D; Czerny M; Doenst T; Emberson JR; Falk V; Gaudino M; McMurray JJV; Mehran R; Milojevic M; Sousa Uva M
Eur Heart J; 2023 Nov; 44(41):4310-4320. PubMed ID: 37632756
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
10. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
[TBL] [Abstract][Full Text] [Related]
11. New-generation stents compared with coronary bypass surgery for unprotected left main disease: A word of caution.
Benedetto U; Taggart DP; Sousa-Uva M; Biondi-Zoccai G; Di Franco A; Ohmes LB; Rahouma M; Kamel M; Caputo M; Girardi LN; Angelini GD; Gaudino M
J Thorac Cardiovasc Surg; 2018 May; 155(5):2013-2019.e16. PubMed ID: 29338862
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
[TBL] [Abstract][Full Text] [Related]
13. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
[TBL] [Abstract][Full Text] [Related]
15. [ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].
Nef H; Renker M; Hamm CW; ;
Herz; 2014 Dec; 39(8):913-8. PubMed ID: 25406330
[TBL] [Abstract][Full Text] [Related]
16. Revascularization of unprotected left main coronary artery disease: strategy selection and systematic risk assessment.
Palmerini T; Alessi L; Dangas G
Catheter Cardiovasc Interv; 2012 Aug; 80(2):199-205. PubMed ID: 22511269
[TBL] [Abstract][Full Text] [Related]
17. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
Mangione FM; Biering-Sørensen T; Nochioka K; Jatene T; Silvestre OM; Hansen KW; Sørensen R; Jensen JS; Jorgensen PG; Jeger R; Kaiser C; Pfisterer M; Galatius S
Catheter Cardiovasc Interv; 2018 Apr; 91(5):867-873. PubMed ID: 28722266
[TBL] [Abstract][Full Text] [Related]
18. Understanding Left Main Disease: Will the Right SYNTAX Help Us EXCEL in (PRE)COMBAT?
Taylor AM; Ragosta M
J Cardiovasc Transl Res; 2015 Jun; 8(4):209-10. PubMed ID: 26031243
[No Abstract] [Full Text] [Related]
19. Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.
Gershlick AH; Kandzari DE; Banning A; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning AP; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Dressler O; Sabik JF; Serruys PW; Kappetein AP; Stone GW
JACC Cardiovasc Interv; 2018 Jul; 11(13):1224-1233. PubMed ID: 29976358
[TBL] [Abstract][Full Text] [Related]
20. Management of Left Main Coronary Artery Disease.
Ramadan R; Boden WE; Kinlay S
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29605817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
